Pituitary Masterclass 2019
Pituitary Masterclass 2019
Pituitary Masterclass 2019
Friday 18th – Saturday 19th October 2019 San Raffaele Congress Centre, Milan, Italy
Pituitary Masterclass 2019
Friday 18th – Saturday 19th October 2019 San Raffaele Congress Centre, Milan, Italy
Video |
5 min
|
Sep 2021
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
The Programme
An educational programme with extensive opportunities for audience participation, sharing and learning through experiences and asking questions to peers and experts.
The Masterclass will start at 12:00 on Friday 18th October and finish at 15:45 on Saturday 19th October. There will be a dinner for all attendees on Friday 18th October.
The detailed programme can be found here: Pituitary Masterclass
The programme will cover the following areas:
- Opening Lecture: Neurosurgery
Plenary Sessions:
- Acromegaly
- PTCOE (Pituitary Tumours Centre of Excellence)
- Cushing’s Disease
- Novel Treatments in pituitary disease
- Special clinical issues in pituitary disease
Meet the Expert Sessions:
- Management of pituitary adenomas
- Outcomes in pituitary adenomas
- Patient session: Acromegaly FAQs
Breakout sessions:
- Aggressive pituitary tumours
- Diabetes insipidus
- Pituitary imaging
Disclosures
SCIENTIFIC COMMITTEE
- Prof Andrea Giustina has the following relevant financial information to disclose: Grants/Consultancy (Abiogen, Astellas, Ipsen, Novartis, Pfizer)
- Prof Felipe Casanueva has the following relevant financial information to disclose: Grants/Consultancy (Ipsen)
- Prof Philippe Chanson has the following relevant financial information to disclose: Grants (Ipsen, Novartis, Novo-Nordisk, Pfizer, Tiburio)
- Prof Maria Fleseriu has the following relevant financial information to disclose: Grants/Consultancy (Chiasma, Ionis, Ipsen, Millendo, Novartis, Novo-Nordisk, Pfizer, Strongbridge)
- Prof Stephan Petersenn has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)
FACULTY
- Prof Pietro Mortini does not have any relevant financial relationship to disclose
- Prof Anton Luger has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novo-Nordisk, Novartis, Pfizer, Sandoz)
- Prof Marco Losa does not have any relevant financial relationship to disclose
- Prof Stefano Frara has the following relevant financial information to disclose: Grants/Consultancy (Ipsen)
- Prof Nienke Biermasz does not have any relevant financial relationship to disclose
- Dr Francesco Tecilazich does not have any relevant financial relationship to disclose
- Dr Anna Formenti has the following relevant financial information to disclose: Grants/Consultancy (Abiogen, Sandoz)
- Prof Luca Persani has the following relevant financial information to disclose: Grants/Consultancy (Merck-Serono, Sandoz)
- Prof Monika Marazuela does not have any relevant financial relationship to disclose
- Prof Martin Reincke does not have any relevant financial relationship to disclose
- Prof Ezio Ghigo does not have any relevant financial relationship to disclose
- Prof AnaMaria Colao has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)
- Prof Thierry Brue has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)
- Prof Laura DeMarinis does not have any relevant financial relationship to disclose
- Dr Eugene Resmini does not have any relevant financial relationship to disclose
- Prof Prof Niki Karavitaki has the following relevant financial information to disclose: Grants/Consultancy (Novartis, Pfizer)
- Prof Paolo Loli does not have any relevant financial relationship to disclose
- Dr Raphael Souillard-Scemama does not have any relevant financial relationship to disclose
PLANNING COMMITTEE
- Iain Murdoch of COR2ED has the following relevant financial information to disclose: Shareholder (AstraZeneca)
This programme is supported by an Independent Educational Grant from Ipsen
PITUITARY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen.